Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the ...

Argus downgraded Moderna (MRNA) to Hold from Buy without a price target The firm sees limited upside for the stock over the next 12 months as ...

BioVaxys Technology (TSE:BIOV) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ...

Moderna 's ( MRNA 3.13%) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock ...

After falling off their perch in the last few months of 2024, European healthcare stocks head into a new year facing the ...

Targovax ASA (GB:0RIS) has released an update. Circio Holding ASA is advancing its innovative circular RNA technology, aiming to revolutionize ...

The 'Fast Money' traders talk the impact of vaccine skepticism on healthcare stocks.

We present three small biotech stocks, which according to Wall Street analysts, have upside potential for 2025.

In the chaotic early days of the pandemic, Wall Street scrambled to place bets on the companies that looked the most likely ...

Pfizer just raised its dividend by 2.4% to $0.43, giving investors something to cheer about despite the stock’s lackluster ...

Pfizer ( SOY-T -1.26% ) on Tuesday forecast 2025 profits roughly in line with Wall Street expectations, offering some relief ...